Water-Soluble Cannabinoid and/or Terpene Extracts for Diverse Therapeutic Applications
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of water-soluble, powdered cannabinoid and/or terpene extracts to address various unmet medical needs across multiple industries, including dermatology, veterinary care, sleep disorders, gut health, and women's health.
Background and Problem Solved
The original patent disclosed a novel method for creating water-soluble, powdered cannabinoid and/or terpene extracts. However, the patent's scope was limited to specific applications. This inventive concept addresses the need for expanding the technology's reach to tackle diverse therapeutic challenges, such as skin conditions, anxiety in pets, sleep quality, gut inflammation, and menstrual cramps.
Detailed Description of the Inventive Concept
The inventive concept involves the application of water-soluble, powdered cannabinoid and/or terpene extracts to various industries, including dermatology, veterinary care, sleep disorders, gut health, and women's health. The extracts are complexed with a cyclodextrin and emulsified with a combination of maltodextrin and acacia, enabling their use in diverse formulations, such as topical creams, treats, capsules, tablets, and transdermal patches. These formulations can provide relief from inflammation, anxiety, insomnia, gut inflammation, and menstrual cramps, among other benefits.
Novelty and Inventive Step
The inventive concept's novelty lies in the expansion of the original technology to address previously unconsidered therapeutic applications, demonstrating a non-obvious and innovative approach to leveraging the core technology. The new claims introduce unexpected and valuable uses for the water-soluble, powdered cannabinoid and/or terpene extracts.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may involve different formulations, such as nasal sprays, suppositories, or injectables, to further expand the technology's reach. Variations may include the use of different cyclodextrins, emulsifiers, or additives to optimize the extracts' performance in specific applications.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential across multiple industries, including pharmaceuticals, veterinary care, cosmetics, and nutraceuticals. The target markets include patients suffering from skin conditions, pet owners seeking anxiety relief for their pets, individuals struggling with sleep disorders, and those experiencing gut inflammation or menstrual cramps. The market size is substantial, with potential revenue streams from licensing, partnerships, and product sales.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K36/185 |
| A | A61 | A61K9/107 |
| A | A61 | A61K47/02 |
| A | A61 | A61K47/36 |
| A | A61 | A61K47/40 |
| A | A61 | A61K47/44 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical and nutraceutical formulations, specifically cannabinoid extract preparation and delivery technologies, involving advanced drug delivery systems, emulsification techniques, and cyclodextrin complexation
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in pharmaceutical sciences, chemistry, or chemical engineering, possessing expertise in drug formulation, extraction technologies, and knowledge of cannabinoid delivery mechanisms, familiar with cyclodextrin complexation and emulsification strategies
Obviousness Rationale
A PHOSITA would recognize that the source patent's water-soluble cannabinoid extraction method provides a foundational technology that can be readily adapted to diverse therapeutic applications. The core technological elements of cyclodextrin complexation, maltodextrin/acacia emulsification, and powdered extract preparation inherently suggest multiple potential medical uses. The PTD's variations represent predictable extensions of the original patent's technological framework, applying known formulation techniques to address specific therapeutic needs.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,589 |
|---|---|
| Title | Water-soluble, powdered cannabinoid and/or terpene extract |
| Assignee(s) | MEDPHARM HOLDINGS, LLC |